Subscribe To
SUBL / Biotech BioLingus files for IPO
BioLingus, a Swiss biotech company incorporated in the Cayman Islands, filed for an IPO on Friday. The company intends to trade on the Nasdaq Capital Market under the ticker symbol “SUBL.
Read More
Posted: Jun 30 2023, 19:31
Author Name: Market Watch
Views: 081056
SUBL News
By Market Watch
June 30, 2023
Biotech BioLingus files for IPO
BioLingus, a Swiss biotech company incorporated in the Cayman Islands, filed for an IPO on Friday. The company intends to trade on the Nasdaq Capital more_horizontal